HRIA
ORKA

Haberer Registered Investment Advisor’s Oruka Therapeutics ORKA Stock Holding History

Haberer Registered Investment Advisor’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3
Closed -$6K – 378
2014
Q3 		$6K Buy
+3
New +$6.26K ﹤0.01% 315

Other funds holding ORKA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Haberer Registered Investment Advisor's ORKA Position: Q4 2014 in Review

Haberer Registered Investment Advisor sold out of Oruka Therapeutics (ORKA) in Q4 2014, closing a stake of 3 shares — an estimated $6K sold.

Haberer Registered Investment Advisor first reported a position in ORKA in Q3 2014 and held it in 1 quarter. The position peaked at $6K in Q3 2014. 11 funds tracked by Wall St. Rank hold ORKA as of Q4 2014.

  • Haberer Registered Investment Advisor reported no remaining Oruka Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Haberer Registered Investment Advisor sold 3 Oruka Therapeutics shares in Q4 2014, an estimated $6K.
  • Haberer Registered Investment Advisor first reported a position in Oruka Therapeutics in Q3 2014 and held it in 1 quarter.
  • Haberer Registered Investment Advisor's Oruka Therapeutics position peaked at $6K in Q3 2014.
  • 11 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q4 2014.

Based on Haberer Registered Investment Advisor's 13F filing for Q4 2014, filed 13 Jan 2015.